https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Horm. Metab. Res. 2008 Feb;40(2):108-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Horm. Metab. Res. 2008 Feb;40(2):108-162008-02-01 00:00:002019-02-15 08:53:23Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Am. J. Hematol. 2008 Feb;83(2):144-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Am. J. Hematol. 2008 Feb;83(2):144-92008-02-01 00:00:002019-02-15 09:25:31Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-112008-02-01 00:00:002008-02-01 00:00:00[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Oncologist 2008 Feb;13(2):175-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Oncologist 2008 Feb;13(2):175-862008-02-01 00:00:002008-02-01 00:00:00Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-442008-02-01 00:00:002019-02-15 08:59:46Dendritic cell-based immunotherapy for malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-212008-02-01 00:00:002019-02-15 08:59:48Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-782008-02-01 00:00:002019-02-15 09:17:40Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-562008-02-01 00:00:002019-02-15 09:17:41Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-702008-02-01 00:00:002019-02-15 09:19:20Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Expert Rev Anticancer Ther 2008 Feb;8(2):243-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Expert Rev Anticancer Ther 2008 Feb;8(2):243-572008-02-01 00:00:002019-02-15 08:52:23Immunotherapy opportunities in ovarian cancer
